PTC Therapeutics, Inc. (PTCT)
USD 49.95
(0.87%)
USD 49.95
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -158.41 Million | -356.65 Million | -251.33 Million | -194.07 Million | -98.63 Million | -27.64 Million |
| Net Income | -626.6 Million | -559.01 Million | -523.9 Million | -438.16 Million | -251.57 Million | -128.08 Million |
| Depreciation & Amortization | 236.59 Million | 128.83 Million | 64.13 Million | 84.87 Million | 32.18 Million | 26.08 Million |
| Deferred income taxes | -46.93 Million | -34.27 Million | 377 Thousand | 5.87 Million | 8.82 Million | -490 Thousand |
| Stock-based compensation | 131.2 Million | 110.33 Million | 103.51 Million | 70.32 Million | 42.13 Million | 33.25 Million |
| Change in working capital | -4 Million | -85.33 Million | -23.78 Million | 36.91 Million | 20.42 Million | 14.2 Million |
| Other non-cash items | 151.32 Million | 82.8 Million | 128.33 Million | 46.1 Million | 49.36 Million | 27.38 Million |
| Investing Cash Flow | -176.73 Million | 290.18 Million | 219.18 Million | -561.54 Million | -387.23 Million | -42.61 Million |
| Investments in PPE | -120.61 Million | -152.46 Million | -85.33 Million | -55.97 Million | -45.43 Million | -15.53 Million |
| Acquisitions | 86.06 Million | 128.43 Million | 57.11 Million | 38.13 Million | -4 Million | -48.89 Million |
| Investment purchases | -212.48 Million | -75.55 Million | -543.26 Million | -1.44 Billion | -494.06 Million | -68.61 Million |
| Sales/Maturities of investments | 156.36 Million | 518.19 Million | 847.77 Million | 944.09 Million | 156.27 Million | 90.42 Million |
| Other Investing Activities | -86.06 Million | -128.43 Million | -57.11 Million | -38.13 Million | -373.48 Million | 13.37 Million |
| Financing Cash Flow | 646.4 Million | 167.95 Million | 20.87 Million | 668.71 Million | 613.2 Million | 131.57 Million |
| Debt repayment | -381.93 Million | -151.27 Million | -2.22 Million | -46.16 Million | -11.66 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 29.99 Million | 50 Million | 23.1 Million | 103.57 Million | 323.75 Million | 117.91 Million |
| Other Financing Activities | 998.33 Million | 269.22 Million | 20.87 Million | 714.87 Million | 301.12 Million | 13.65 Million |
| Accounts receivables | -1.53 Million | -48.46 Million | -44.99 Million | -10.48 Million | 11.52 Million | -29.58 Million |
| Accounts payables | 48.34 Million | 27.54 Million | 23.41 Million | 53.58 Million | 13.74 Million | 43.1 Million |
| Inventory | -8.18 Million | -6.66 Million | 1.8 Million | 1.84 Million | -3.45 Million | -5.82 Million |
| Other working capital | -42.62 Million | -57.74 Million | -4.01 Million | -8.03 Million | -1.38 Million | 6.51 Million |
| Cash at beginning of period | 279.83 Million | 197.21 Million | 216.31 Million | 295.52 Million | 169.49 Million | 111.79 Million |
| Cash at end of period | 594 Million | 295.92 Million | 197.21 Million | 216.31 Million | 295.52 Million | 169.49 Million |
| Capital Expenditure | -120.61 Million | -152.46 Million | -85.33 Million | -55.97 Million | -45.43 Million | -15.53 Million |
| Effect of forex changes on cash | 3.11 Million | -2.77 Million | -7.82 Million | 7.68 Million | -1.3 Million | -3.61 Million |
| Net cash flow / Change in cash | 314.16 Million | 98.7 Million | -19.09 Million | -79.21 Million | 126.03 Million | 57.7 Million |
| Free Cash Flow | -279.03 Million | -509.11 Million | -336.66 Million | -250.04 Million | -144.07 Million | -43.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -99.17 Million | -91.57 Million | -626.6 Million | -155.79 Million | -132.97 Million | -198.88 Million |
| Depreciation & Amortization | 7.01 Million | 55.39 Million | 236.59 Million | 80.7 Million | 62.05 Million | 51 Million |
| Deferred income taxes | 2000.00 | -1000.00 | -46.93 Million | 3.97 Million | -2000.00 | -50.9 Million |
| Stock-based compensation | 19.24 Million | 18.37 Million | 131.2 Million | 16.5 Million | 56.51 Million | 29.37 Million |
| Change in working capital | -11.17 Million | 65.51 Million | -4 Million | -82.61 Million | 7.5 Million | 32.38 Million |
| Other non-cash items | 39.66 Million | 191.6 Million | 151.32 Million | 36.92 Million | -7.62 Million | 122.9 Million |
| Investing Cash Flow | -65.92 Million | -114.93 Million | -176.73 Million | -94.41 Million | -29.59 Million | -23.75 Million |
| Investments in PPE | 7.37 Million | -64.35 Million | -120.61 Million | -28.46 Million | -29.2 Million | -19.28 Million |
| Acquisitions | 28.03 Million | - | 86.06 Million | -35.88 Million | 22.84 Million | 13.03 Million |
| Investment purchases | -195.7 Million | -113.43 Million | -212.48 Million | -186.1 Million | -8.21 Million | -18.15 Million |
| Sales/Maturities of investments | 94.36 Million | 62.85 Million | 156.36 Million | 120.15 Million | 7.82 Million | 13.69 Million |
| Other Investing Activities | 28.03 Million | -105.34 Million | -86.06 Million | 35.88 Million | -22.84 Million | -13.03 Million |
| Financing Cash Flow | 246.48 Million | 540 Thousand | 646.4 Million | 620.48 Million | 3.36 Million | 18.46 Million |
| Debt repayment | - | -1.49 Million | -381.93 Million | -381.65 Million | -1.29 Million | -15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.69 Million | 2.02 Million | 29.99 Million | 2.41 Million | 3.44 Million | 18.47 Million |
| Other Financing Activities | 241.79 Million | 2.03 Million | 998.33 Million | 999.71 Million | 1.2 Million | -15 Thousand |
| Accounts receivables | 8.18 Million | -39.5 Million | -1.53 Million | 8.34 Million | 8.13 Million | 25.4 Million |
| Accounts payables | - | -5.38 Million | 48.34 Million | -30 Thousand | 2.47 Million | 12.37 Million |
| Inventory | -1.93 Million | 120 Thousand | -8.18 Million | 5.93 Million | -4.32 Million | -5.18 Million |
| Other working capital | -17.43 Million | 104.89 Million | -42.62 Million | -96.86 Million | 1.22 Million | -214 Thousand |
| Cash at beginning of period | 548.35 Million | 594 Million | 279.83 Million | 165.15 Million | 224.49 Million | 233.59 Million |
| Cash at end of period | 654.77 Million | 548.35 Million | 594 Million | 594 Million | 181.41 Million | 224.49 Million |
| Capital Expenditure | 7.37 Million | -64.35 Million | -120.61 Million | -28.46 Million | -29.2 Million | -19.28 Million |
| Effect of forex changes on cash | -5.18 Million | -2.03 Million | 3.11 Million | 3.09 Million | -2.33 Million | 10.31 Million |
| Net cash flow / Change in cash | 106.42 Million | -45.64 Million | 314.16 Million | 428.84 Million | -43.08 Million | -9.09 Million |
| Free Cash Flow | -64.07 Million | 6.41 Million | -279.03 Million | -128.75 Million | -43.72 Million | -33.4 Million |
PMMEF
ARR
TOTS3
EDELWEISS
EUUNF
IQV